Navigation Links
IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial

new cases are expected to be diagnosed and it is estimated that approximately 8,110 people in the United Sates will die from the disease.

About IDM Pharma

IDM Pharma (IDM) is a biopharmaceutical company focused on the development of innovative products that activate the immune system to treat cancer. IDM's lead product candidate, JUNOVAN(TM) (mifamurtide for injection), known as MEPACT in Europe, is part of a new family of immunotherapeutic agents designed to destroy residual cancer cells by activating the body's natural defenses. IDM's applications requesting marketing approval of JUNOVAN for use in the treatment of newly diagnosed resectable high-grade osteosarcoma patients in combination with multiple agent chemotherapy are under review by the U.S. Food and Drug Administration, or FDA, in the United States and by the European Medicines Agency, or EMEA, in Europe. IDM is jointly developing UVIDEM, a cell-based vaccine product candidate in Phase II clinical trials for the treatment of melanoma, with sanofi-aventis. EP-2101 is currently being tested in non-small cell lung cancer (NSCLC) patients in a Phase II clinical trial and is composed of multiple tumor-specific CTL epitopes selected from tumor- associated antigens.

For more information, visit http://www.idm-pharma.com.

About sanofi-aventis

Sanofi-aventis is one of the world leaders in the pharmaceutical industry, ranking number one in Europe. Backed by a world-class R&D organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine and vaccines. Sanofi-aventis is listed in Paris and in New York .

Forward-Looking Statements

This press release includes and the presentation described in this press release will include forward-looking statements that reflect management's curr
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
Post Your Comments:
(Date:5/26/2015)... Calif. , May 26, 2015  Amgen (NASDAQ: ... results from the Phase 3 OPTiM study in the ... . The data published in JCO , ... the American Society of Clinical Oncology (ASCO) in 2013 ... (DRR) in patients with unresected stage IIIB, IIIC or ...
(Date:5/26/2015)... --  Generational Equity , a leading mergers and acquisitions ... the acquisition of its client, Peaks & Plains ... , by Mi-Med Supply , headquartered in Vista, ... Peaks & Plains is the only dual ... nutritional, patient care, and housekeeping equipment to long-term care ...
(Date:5/26/2015)... 26, 2015 Clinicient Inc , ... announced the results of an industry survey of ... 759 therapists, practice owners and administrative staff completed ... need for technology and services that improve therapist ... findings, Clinicient published a free 12-page guide to ...
Breaking Medicine Technology:Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 2Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 3Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 4Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 5Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 6Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 7Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 8Generational Equity Announces the Acquisition of Peaks & Plains Inc. by Mi-Med Supply 2Survey: Half of Physical Therapists Underbill For Their Services 2
... #4061DENVER, April 21 Scientists from the Barbara ... today at the American Association for Cancer Research,s ... a brighter future for children who suffer from ... http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO )Yubin Ge, Ph.D., and Chengzhi Xie, Ph.D., ...
... and Arisyn Therapeutics jointly announced today the successful ... Health to support the development of novel small ... virus (HCV) infection. ImQuest scientists will investigate ... ATI-0810 (Formerly PG301029) and a series of related ...
Cached Medicine Technology:Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia 2Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia 3ImQuest BioSciences Receives Phase I SBIR Grant to Develop a Novel Hepatitis C Virus Therapeutic Agent 2
(Date:5/26/2015)... Two addiction experts from ... Pei on a CNBC radio podcast for a ... on KCAA AM 1050, the podcast features Tim Salyer, ... therapist, as they discuss current statistics on drug and ... 23.5 million Americans. The program, titled “Addiction, Self-Hatred, Hope ...
(Date:5/26/2015)... May 26, 2015 Relias Learning ... for the health and human services market, announces expansion ... demand. After strong attendance and participation in 2014, they ... give their annual user conference an exciting new facelift. ... to come together and discuss best practices, share their ...
(Date:5/26/2015)... 2015 Synthetic cannabinoids attempt to ... article published by International Business Times ... Spice, and black mamba) causes unpredictable medical and ... substances make it nearly impossible for medical doctors ... the substance due to the frequency in which ...
(Date:5/26/2015)... Pasadena porcelain veneers dentist, Dr. Marine ... treatments. Cosmetic dentistry is becoming increasingly popular in today’s ... committed to providing you with the highest level of ... a smile of a lifetime … We work with ... change your life,” explains Dr. Martirosyan’s team. “Giving you ...
(Date:5/26/2015)... Indosoft, Inc ., developer of ... DMi Partners contact center to Q-Suite 5.8 call ... contact center ACD system to drop Asterisk 1.4 support. ... trunk features as diversion headers, added Lyra support via ... to warm transfers to improve information handling ...
Breaking Medicine News(10 mins):Health News:Anaheim Lighthouse Staff Joined Dr. Marissa Pei’s in a Conversation on Drug and Alcohol Addiction 2Health News:Anaheim Lighthouse Staff Joined Dr. Marissa Pei’s in a Conversation on Drug and Alcohol Addiction 3Health News:Relias Learning Expands User Groups and Industry Influence 2Health News:Relias Learning Expands User Groups and Industry Influence 3Health News:Synthetic Cannabinoids Can Cause Psychotic Episodes; Doctors at a Loss for Treatment 2Health News:Synthetic Cannabinoids Can Cause Psychotic Episodes; Doctors at a Loss for Treatment 3Health News:Pasadena Porcelain Veneers Expert, Marine Martirosyan DDS, is Now Offering Complimentary Dental Cleaning with Cosmetic Treatments 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 3
... at the Stanford University School of Medicine have devised a ... virtually separate a whole-blood sample into its different cell types ... of those cell types. In a study to be ... scientists reported that they had successfully used the new technique ...
... that much harder to eliminate, scientists say , SUNDAY, March ... the AIDS virus in the blood to zero, but HIV ... their pills. Now, research is giving scientists new insight into ... powers of medicine. , In a new study, researchers ...
... ... residents in hypertension therapy and sleep disorders will receive international recognition at the American ... ... work of two St. Elizabeth Internal Medicine residents in hypertension therapy and sleep disorders ...
... ... certification. Their revolutionary line of quick couplings and plastic fittings are all designed, ... ... -- Kent Systems received their Made in the USA Brand certification. Their revolutionary ...
... ... the 2010 Cinco de Mayo Half Marathon and the 12th Annual “Reaching for the Cure” ... ... Research Foundation (PCRF) announced the official sponsors for the annual “Reaching for the Cure” ...
... Age ... specialist-expert and nutritionist counselor, Rod Stanley, to give patients 1:1 attention and superior fitness ... ... expert and age management medicine icon, is boosting patient motivational levels by adding his ...
Cached Medicine News:Health News:Mathematical innovation turns blood draw into information gold mine in Stanford study 2Health News:Mathematical innovation turns blood draw into information gold mine in Stanford study 3Health News:Mathematical innovation turns blood draw into information gold mine in Stanford study 4Health News:HIV Hides Out in Bone Marrow Cells 2Health News:St. Elizabeth Medical Residents to Present Research at International Meeting, 2Health News:Kent Systems Received Made in the USA Brand Certification 2Health News:Sponsors for the 2010 Pediatric Cancer Research Foundation “Reaching for the Cure” Annual Cinco de Mayo Run/Walk Fundraising Event 2Health News:Sponsors for the 2010 Pediatric Cancer Research Foundation “Reaching for the Cure” Annual Cinco de Mayo Run/Walk Fundraising Event 3Health News:Healthy Aging Icon Ups Patient Motivational Levels, Signs His Personal Trainer To Age-Management Team 2Health News:Healthy Aging Icon Ups Patient Motivational Levels, Signs His Personal Trainer To Age-Management Team 3
Built-in convexity means added security and skin protection for recessed, retracted and flush stomas...pre-cut openings. Security and confidence achieved by the internal No-Flowback Valves and soft d...
Inquire...
Inquire...
Inquire...
Medicine Products: